Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
17 Jul 2016
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Advances in early detection
Changing landscape of multiple myeloma care: Expert discussion
Monitoring the cancer genome in plasma using circulating tumour DNA
Cancer organoids
Prostate cancer screening: A north/south comparison in Ireland
Sequencing analysis with circulating DNA
Large disparities found in BCRA testing across ethnicities
Radiotherapy in Hogkin lymphoma: reducing risk in later life
A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer
Multiplex IHC as biomarkers for cancer immunotherapy
Integrating multiple omics information in the era of precision oncology